IVIEW Therapeutics’ IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis
China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the...
IVIEW Therapeutics
IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline
IVIEW Therapeutics Inc., an ophthalmology biotech operating out of the US and China, has reportedly...